Observational Study
Copyright ©The Author(s) 2016.
World J Diabetes. Nov 15, 2016; 7(19): 547-553
Published online Nov 15, 2016. doi: 10.4239/wjd.v7.i19.547
Figure 4
Figure 4 Terminal Latency in sensory component of Left Ulnar nerve at baseline and 3 mo (Shaded bar: Pioglitazone; White bar: Non Pioglitazone arm). aP = 0.161, cP = 0.038 (Wilcoxon matched pairs signed rank sum test). L-U-sensory-TL: Terminal Latency in sensory component of Left Ulnar nerve.